Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27491-27500 Newer>

The Motley Fool November 30, 2007 Brian Lawler	FDA Throws Adolor a Bone Pharmaceutical company Adolor gets an advisory panel hearing on its lead drug. Investors, take note.
The Motley Fool November 30, 2007 Ryan Fuhrmann	Fool on the Street: Is Eagle Materials Built to Last? Despite significant near-term challenges, Eagle Materials has a solid, long-term game plan.
The Motley Fool November 30, 2007 Rich Smith	American Pockmarked Management at American Woodmark blamed "inefficiencies in labor and overhead costs stemming from the impact of lower sales volumes, higher medical costs, and rising fuel costs," for their 86% decline in per-share profits in Q2.
The Motley Fool November 30, 2007 David Lee Smith	Oceaneering Is Capable of a Big Splash Given both its unique position in the industry and the progressive move to deep water in the search for oil and gas, it's tough to imagine Oceaneering not expanding and prospering in the future.
The Motley Fool November 30, 2007 Jason Ramage	Fred's Searching for Wilma General merchandiser Fred's announces in its third-quarter earnings report that there have been multiple buyout inquiries regarding the company.
The Motley Fool November 30, 2007 Brian Lawler	Not What Trimeris Needs Small biopharma Trimeris revealed that it and partner Roche were being sued for patent infringement by Novartis over Trimeris' only marketed compound, Fuzeon.
The Motley Fool November 30, 2007 Rich Smith	Bud Buries the Punch Line Despite rising raw-material costs, Anheuser-Busch seems pretty confident that it will exceed its long-term goal of 7% to 10% per-share profits growth this year.
The Motley Fool November 30, 2007 Brian Orelli	Increased Potency Increases Stock Price Sirtris Pharmaceuticals publishes an article this week in Nature that characterized its discovery of drugs that are 1000 times more potent than resveratrol, the compound found in red wine that makes mice live longer and lowers blood sugar levels in obese mice.
The Motley Fool November 30, 2007 Rick Aristotle Munarriz	Fool on the Street: Amazon's Big Fat Secret Amazon.com has matured into not just an Internet retailer. It is the Internet retailer. And that's a pretty powerful thing.
The Motley Fool November 30, 2007 Anders Bylund	Hey, Mr. Market! Dell Deserves Better! Dell is down following earnings reports, but for all the wrong reasons. Maybe it's time to buy.
<Older 27491-27500 Newer> Return to current articles.